FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912794054> ?p ?o ?g. }

• W2912794054 endingPage "156" @default.
• W2912794054 startingPage "146" @default.
• W2912794054 abstract "Background: Corticosteroids are the preferred option to treat asthma, however, they possess serious side effects and are inefficient in 10% of patients. Thus, new therapeutic approaches for asthma treatment are required. Objective: To study the efficacy of a novel glutarimide derivative XC8 in a Sephadex-induced lung inflammation in rats as well as in acute and chronic ovalbumin-induced allergic asthma in guinea pigs. Method: Rats were treated with 0.18-18 mg/kg of XC8 intragastrically 4 times (24 h and 1 h prior to and 24 h and 45 h after endotracheal administration of Sephadex). The number of inflammatory cells in bronchoalveaolar lavages (BAL) was determined. Guinea pigs were treated with 0.045 -1.4 mg/kg (acute asthma) or with 1.4 and 7.0 mg/kg of XC8 (chronic asthma) intragastrically following the sensitization with ovalbumin and during aerosol challenge. Lung inflammation, numbers of eosinophils (BAL and lung tissue), goblet cells, degranulating mast cells and specific airway resistance (sRAW) were determined. The comparator steroid drug budesonide (0.5 mg/kg for rats and 0.16 mg/kg for guinea pigs) was administered by inhalation. Results: XC8 reduced influx of eosinophils into BAL in Sephadex-induced lung inflammation model in rats (by 2.6-6.4 times). Treatment of acute asthma in guinea pigs significantly reduced eosinophils in guinea pigs in BAL (from 55% to 30%-39% of the total cell count) and goblet cells in lung tissue. In a model of acute and chronic asthma, XC8 reduced significantly the number of eosinophils and degranulating mast cells in the lung tissue. Treatment with XC8 but not with budesonide decreased the specific airway resistance in acute and chronic asthma model up to the level of naive animals. Conclusion: XC8 induced a profound anti-inflammatory effect by reducing eosinophils in BAL and eosinophils and degranulating mast cell numbers in the airway tissue. The anti-asthmatic effect of XC8 is comparable to that of budesonide. Moreover, in contrast to budesonide, XC8 was capable to reduce goblet cells and airway resistance." @default.
• W2912794054 created "2019-02-21" @default.
• W2912794054 creator A5004116666 @default.
• W2912794054 creator A5006694993 @default.
• W2912794054 creator A5012644905 @default.
• W2912794054 creator A5016113791 @default.
• W2912794054 creator A5020100053 @default.
• W2912794054 creator A5023731581 @default.
• W2912794054 creator A5024246795 @default.
• W2912794054 creator A5043194252 @default.
• W2912794054 creator A5043500089 @default.
• W2912794054 date "2019-04-16" @default.
• W2912794054 modified "2023-09-26" @default.
• W2912794054 title "A Novel Oral Glutarimide Derivative XC8 Suppresses Sephadex-Induced Lung Inflammation in Rats and Ovalbumin-induced Acute and Chronic Asthma in Guinea Pigs" @default.
• W2912794054 cites W1516427878 @default.
• W2912794054 cites W1517597786 @default.
• W2912794054 cites W1550989824 @default.
• W2912794054 cites W1723887941 @default.
• W2912794054 cites W1912613430 @default.
• W2912794054 cites W1966242724 @default.
• W2912794054 cites W1972318181 @default.
• W2912794054 cites W1982336794 @default.
• W2912794054 cites W1991648511 @default.
• W2912794054 cites W1994508335 @default.
• W2912794054 cites W1998154445 @default.
• W2912794054 cites W2001682714 @default.
• W2912794054 cites W2002438634 @default.
• W2912794054 cites W2006132848 @default.
• W2912794054 cites W2013506651 @default.
• W2912794054 cites W2015105473 @default.
• W2912794054 cites W2017022988 @default.
• W2912794054 cites W2018226872 @default.
• W2912794054 cites W2035198085 @default.
• W2912794054 cites W2042158404 @default.
• W2912794054 cites W2043990114 @default.
• W2912794054 cites W2049666632 @default.
• W2912794054 cites W2057424438 @default.
• W2912794054 cites W2060800884 @default.
• W2912794054 cites W2061623411 @default.
• W2912794054 cites W2069845084 @default.
• W2912794054 cites W2104718344 @default.
• W2912794054 cites W2127639563 @default.
• W2912794054 cites W2144836517 @default.
• W2912794054 cites W2153231621 @default.
• W2912794054 cites W2159556499 @default.
• W2912794054 cites W2160134481 @default.
• W2912794054 cites W2164852931 @default.
• W2912794054 cites W2166600234 @default.
• W2912794054 cites W2170364105 @default.
• W2912794054 cites W2767953804 @default.
• W2912794054 cites W36864454 @default.
• W2912794054 cites W751328058 @default.
• W2912794054 doi "https://doi.org/10.2174/1389201020666190215103505" @default.
• W2912794054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30767739" @default.
• W2912794054 hasPublicationYear "2019" @default.
• W2912794054 type Work @default.
• W2912794054 sameAs 2912794054 @default.
• W2912794054 citedByCount "3" @default.
• W2912794054 countsByYear W29127940542019 @default.
• W2912794054 countsByYear W29127940542020 @default.
• W2912794054 countsByYear W29127940542022 @default.
• W2912794054 crossrefType "journal-article" @default.
• W2912794054 hasAuthorship W2912794054A5004116666 @default.
• W2912794054 hasAuthorship W2912794054A5006694993 @default.
• W2912794054 hasAuthorship W2912794054A5012644905 @default.
• W2912794054 hasAuthorship W2912794054A5016113791 @default.
• W2912794054 hasAuthorship W2912794054A5020100053 @default.
• W2912794054 hasAuthorship W2912794054A5023731581 @default.
• W2912794054 hasAuthorship W2912794054A5024246795 @default.
• W2912794054 hasAuthorship W2912794054A5043194252 @default.
• W2912794054 hasAuthorship W2912794054A5043500089 @default.
• W2912794054 hasConcept C126322002 @default.
• W2912794054 hasConcept C147483822 @default.
• W2912794054 hasConcept C203014093 @default.
• W2912794054 hasConcept C2776042228 @default.
• W2912794054 hasConcept C2776136866 @default.
• W2912794054 hasConcept C2776217527 @default.
• W2912794054 hasConcept C2776914184 @default.
• W2912794054 hasConcept C2776946954 @default.
• W2912794054 hasConcept C2776954882 @default.
• W2912794054 hasConcept C2777714996 @default.
• W2912794054 hasConcept C2778815084 @default.
• W2912794054 hasConcept C42219234 @default.
• W2912794054 hasConcept C71924100 @default.
• W2912794054 hasConcept C98274493 @default.
• W2912794054 hasConceptScore W2912794054C126322002 @default.
• W2912794054 hasConceptScore W2912794054C147483822 @default.
• W2912794054 hasConceptScore W2912794054C203014093 @default.
• W2912794054 hasConceptScore W2912794054C2776042228 @default.
• W2912794054 hasConceptScore W2912794054C2776136866 @default.
• W2912794054 hasConceptScore W2912794054C2776217527 @default.
• W2912794054 hasConceptScore W2912794054C2776914184 @default.
• W2912794054 hasConceptScore W2912794054C2776946954 @default.
• W2912794054 hasConceptScore W2912794054C2776954882 @default.
• W2912794054 hasConceptScore W2912794054C2777714996 @default.
• W2912794054 hasConceptScore W2912794054C2778815084 @default.
• W2912794054 hasConceptScore W2912794054C42219234 @default.
• W2912794054 hasConceptScore W2912794054C71924100 @default.

• next